is bpc-157 on fda 503a bulks list FDA's own advisory committee voted 8-6 Thursday. BPC-157, the compounding now, for ulcerative colitis. staff argued against it, laid out the data gaps, the whole case. Panel overruled them FDA staff recommends against adding

FDA staff recommends against adding any of these 7 peptides to the 503A Bulks List: BPC 157 (free base acetate) KPV (free base acetate) TB 500 (free base acetate) MOTS c (free base acetate) The FDA just dropped a 68 page PDF on if BPC 157 should be legal or not to compound. Their initial recommendation: DO NOT add BPC 157 to the 503A Bulks List. They're meeting this FDA panel backs compounded BPC 157, KPV peptides in win for RFK Jr. STAT bpc 157 regulation fda fda bpc 157 category 2 bulk drug substances compounding list When will the FDA reclassify BPC 157 to Category 1

SKU: 20991609221 · From iglepidom.org